Hutner Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.7M | Sell |
40,006
-1,866
| -4% | -$414K | 3.57% | 11 |
|
|
2025
Q4 | $9.57M | Sell |
41,872
-248
| -0.6% | -$56.5K | 3.99% | 9 |
|
|
2025
Q3 | $9.75M | Buy |
42,120
+156
| +0.4% | +$31.8K | 4.13% | 8 |
|
|
2025
Q2 | $7.79M | Sell |
41,964
-1,132
| -3% | -$210K | 3.54% | 8 |
|
|
2025
Q1 | $9.03M | Buy |
43,096
+693
| +2% | +$135K | 3.85% | 8 |
|
|
2024
Q4 | $7.54M | Buy |
42,403
+3,901
| +10% | +$717K | 3.64% | 9 |
|
|
2024
Q3 | $7.6M | Sell |
38,502
-63
| -0.2% | -$11.8K | 3.78% | 9 |
|
|
2024
Q2 | $6.61M | Sell |
38,565
-500
| -1% | -$82.8K | 3.63% | 9 |
|
|
2024
Q1 | $7.11M | Buy |
39,065
+7
| +0% | +$1.21K | 3.86% | 8 |
|
|
2023
Q4 | $6.05M | Sell |
39,058
-832
| -2% | -$121K | 3.57% | 10 |
|
|
2023
Q3 | $5.95M | Sell |
39,890
-394
| -1% | -$57.8K | 3.65% | 10 |
|
|
2023
Q2 | $5.43M | Buy |
40,284
+17
| +0% | +$2.49K | 3.17% | 10 |
|
|
2023
Q1 | $6.42M | Buy |
40,267
+85
| +0.2% | +$13K | 3.91% | 10 |
|
|
2022
Q4 | $6.49M | Buy |
40,182
+433
| +1% | +$66.4K | 4.02% | 10 |
|
|
2022
Q3 | $5.33M | Buy |
39,749
+91
| +0.2% | +$13.1K | 3.73% | 10 |
|
|
2022
Q2 | $6.07M | Sell |
39,658
-81
| -0.2% | -$12.4K | 3.99% | 10 |
|
|
2022
Q1 | $6.44M | Sell |
39,739
-158
| -0.4% | -$23K | 3.68% | 10 |
|
|
2021
Q4 | $5.4M | Sell |
39,897
-395
| -1% | -$46.7K | 3.15% | 12 |
|
|
2021
Q3 | $4.35M | Buy |
40,292
+186
| +0.5% | +$21.3K | 2.84% | 13 |
|
|
2021
Q2 | $4.52M | Sell |
40,106
-677
| -2% | -$76.2K | 2.89% | 13 |
|
|
2021
Q1 | $4.41M | Buy |
40,783
+2,383
| +6% | +$255K | 2.89% | 13 |
|
|
2020
Q4 | $4.12M | Buy |
38,400
+86
| +0.2% | +$8.26K | 2.87% | 13 |
|
|
2020
Q3 | $3.36M | Buy |
38,314
+4,265
| +13% | +$402K | 2.49% | 15 |
|
|
2020
Q2 | $3.34M | Buy |
34,049
+9,256
| +37% | +$815K | 2.83% | 13 |
|
|
2020
Q1 | $1.89M | Sell |
24,793
-50
| -0.2% | -$4.26K | 1.73% | 20 |
|
|
2019
Q4 | $2.2M | Sell |
24,843
-210
| -0.8% | -$17.4K | 1.52% | 24 |
|
|
2019
Q3 | $1.9M | Hold |
25,053
| – | – | 1.34% | 24 |
|
|
2019
Q2 | $1.82M | Hold |
25,053
| – | – | 1.3% | 24 |
|
|
2019
Q1 | $2.02M | Sell |
25,053
-942
| -4% | -$77.1K | 1.48% | 24 |
|
|
2018
Q4 | $2.4M | Buy |
25,995
+730
| +3% | +$64.2K | 1.87% | 21 |
|
|
2018
Q3 | $2.39M | Hold |
25,265
| – | – | 1.73% | 22 |
|
|
2018
Q2 | $2.34M | Sell |
25,265
-520
| -2% | -$50.8K | 1.83% | 21 |
|
|
2018
Q1 | $2.44M | Sell |
25,785
-50
| -0.2% | -$5.49K | 1.9% | 19 |
|
|
2017
Q4 | $2.5M | Hold |
25,835
| – | – | 1.78% | 20 |
|
|
2017
Q3 | $2.3M | Hold |
25,835
| – | – | 1.74% | 20 |
|
|
2017
Q2 | $1.87M | Sell |
25,835
-485
| -2% | -$32.6K | 1.44% | 22 |
|
|
2017
Q1 | $1.72M | Sell |
26,320
-672
| -2% | -$42.2K | 1.35% | 23 |
|
|
2016
Q4 | $1.69M | Sell |
26,992
-1,350
| -5% | -$82.4K | 1.4% | 23 |
|
|
2016
Q3 | $1.79M | Buy |
+28,342
| New | +$1.83M | 1.52% | 24 |
|
Other funds holding ABBV
VCM
VPM
Hutner Capital Management's ABBV Position: Q1 2026 in Review
Hutner Capital Management reduced its AbbVie (ABBV) stake by 4.5% in Q1 2026, selling an estimated $414K and leaving 40,006 shares worth $8.7M. The position accounts for 3.57% of the portfolio, ranked #11.
Hutner Capital Management first reported a position in ABBV in Q3 2016 and has held it in 39 quarters since. The position peaked at $9.75M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Hutner Capital Management held 40,006 shares of AbbVie worth $8.7M as of Q1 2026.
- Hutner Capital Management sold 1,866 AbbVie shares in Q1 2026, an estimated $414K.
- AbbVie made up 3.57% of Hutner Capital Management's portfolio in Q1 2026, its #11 holding.
- Hutner Capital Management first reported a position in AbbVie in Q3 2016 and has held it in 39 quarters since.
- Hutner Capital Management's AbbVie position peaked at $9.75M in Q3 2025.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Hutner Capital Management's 13F filing for Q1 2026, filed 15 May 2026.